Tanudra, Juanito R.
HRN: 03-30-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2025
MUPIROCIN 2%, 15G (TUBE)
04/29/2025
05/08/2025
DERMAL
1
BID
NONHEALINF WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes